Three-year follow-up from CheckMate 017/057: Nivolumab versus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC)

Affiliation auteurs!!!! Error affiliation !!!!
TitreThree-year follow-up from CheckMate 017/057: Nivolumab versus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC)
Type de publicationJournal Article
Year of Publication2017
AuteursE. Font F, Gettinger S.N, Burgio M.A, Antonia S.J, Holgado E., Spigel D.R, Arrieta O., M. Gomez D, O. Frontera A, Brahmer J., Chow L.Q, Crino L., Butts C., Coudert B., Horn L., Steins M., Geese W.J, Li A., Healey D., Vokes E.E
JournalANNALS OF ONCOLOGY
Volume28
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534